Skip to main content

Table 3 Prevalence ratios¶ for the associations between dependence and self-reported impairments and diagnoses, by site

From: "The contribution of chronic diseases to the prevalence of dependence among older people in Latin America, China and India: a 10/66 Dementia Research Group population-based survey"

 

Cuba

Dominican Republic

Urban Peru

Rural Peru

Venezuela

Urban Mexico

Rural Mexico

Urban China

Rural China

Urban India

Rural India

Meta-analysed PR (95% CI)

Cochran's Q Higgins I 2 (95% CI)

PAPF median (range)

Dementia

9.46

(7.01-12.7)

2.79

(2.11-3.68)

6.76

(4.22-10.83)

8.05

(2.93-22.1)

4.21

(3.05-5.82)

4.55

(3.06-6.75)

3.58

(2.28-5.64)

3.60

(2.60-4.9)

5.35

(3.09-9.29)

9.29

(3.72-23.2)

2.87

(1.83-4.51)

4.49

(3.98-5.07)

Q = 48.69

I2 = 79%

34%

(23-59)

PAPF

59%

27%

47%

38%

28%

34%

23%

29%

42%

45%

24%

 

(64-88)

 

Paralysis/weakness

1.87

(1.36-2.57)

3.77

(2.82-5.03)

2.02

(1.08-3.77)

4.94

(1.63-14.9)

1.13

(0.69-1.83)

1.95

(1.13-3.37)

3.40

(2.04-5.67)

3.01

(1.89-4.79)

13.27

(7.24-24.3)

1.76

(0.22-13.9)

2.90

(1.33-6.30)

2.76

(2.38-3.20)

Q = 53.42

I2 = 81%

9%

(1-46)

PAPF

6%

20%

9%

6%

2%

5%

10%

20%

46%

1%

12%

 

(68-89)

 

Stroke

1.78

(1.36-2.33)

1.27

(0.9-1.76)

2.40

(1.43-4.03)

3.01

(0.69-13.0)

2.04

(1.41-2.95)

1.92

(1.19-3.11)

2.60

(1.62-4.17)

1.31

(0.84-2.1)

1.23

(0.59-2.57)

3.86

(1.40-10.6)

2.87

(1.13-7.33)

1.78

(1.55-2.05)

Q = 15.10

I2 = 34%

8%

(2-17)

PAPF

10%

5%

17%

7%

11%

8%

13%

7%

2%

10%

6%

 

(0-67)

 

Depression

1.56

(1.08-2.24)

2.79

(2.11-3.68)

2.06

(1.35-3.15)

5.25

(1.51-18.2)

2.30

(1.43-3.69)

0.93

(0.47-1.83)

2.55

(1.52-4.27)

1.00

(0.41-2.43)

1.11

(0.61-2.02)

2.57

(0.89-7.42)

1.84

(1.03-3.29)

1.70

(1.46-1.98)

Q = 15.63

I2 = 36%

8%

(0-27)

PAPF

3%

27%

7%

16%

8%

0

8%

0

1%

10%

10%

 

(0-69)

 

Eyesight problems

1.21

(0.97-1.50)

1.40

(1.12-1.84)

1.20

(0.82-1.75)

0.72

(0.30-1.74)

0.95

(0.70-1.29)

1.36

(0.96-1.94)

0.92

(0.59-1.45)

1.18

(0.85-1.64)

1.79

(0.94-3.39)

2.06

(0.46-9.13)

1.12

(0.70-1.80)

1.20

(1.08-1.34)

Q = 9.37

I2 = 0 (0-60)

6%

(0-16)

PAPF

7%

16%

7%

0

0

11%

0

3%

6%

7%

3%

   

Arthritis/rheumatism

1.18

(0.93-1.50)

0.93

(0.72-1.20)

1.29

(0.89-1.88)

0.53

(0.11-2.50)

1.87

(0.85-1.65)

1.32

(0.85-2.04)

0.87

(0.56-1.37)

1.50

(1.07-2.10)

0.71

(0.15-3.28)

1.05

(0.42-2.59)

1.07

(0.66-1.74)

1.13

(1.01-1.27)

Q = 8.73

I2 = 0 (0-60)

4%

(0-6)

PAPF

4%

0

5%

0

5%

5%

0

6%

0

0

4%

   

Stomach/intestine problems

0.86

(0.62-1.18)

1.10

(0.82-1.48)

1.01

(0.67-1.54)

3.71

(1.13-12.2)

0.72

(0.50-1.04)

1.10

(0.69-1.76)

1.98

(1.29-3.05)

1.12

(0.72-1.74)

4.22

(1.08-16.4)

NC

1.39

(0.74-2.59)

1.09

(0.95-1.25)

Q = 23.16

I 2 = 61%

(22-81)

1.5%

(0-16)

PAPF

0

2%

0

11%

0

1%

16%

0

4%

 

2%

   

Hearing difficulty

1.07

(0.82-1.39)

1.32

(0.99-1.75)

0.95

(0.65-1.38)

1.31

(0.40-4.28)

1.10

(0.75-1.59)

0.98

(0.66-1.46)

0.83

(0.52-1.34)

1.04

(0.75-1.46)

0.97

(0.52-1.80)

NC

1.09

(0.66-1.80)

1.06

(0.92-1.21)

Q = 4.38

I 2 = 0 (0-62)

1%

(0-5)

PAPF

1%

5%

0

4%

2%

0

0

1%

0

 

2%

   

Difficulty breathing

1.17

(0.73-1.89

0.91

(0.63-1.33)

1.39

(0.72-2.68)

0.46

(0.12-1.65)

1.22

(0.78-1.91)

1.47

(0.70-3.11)

1.04

(0.46-2.34)

1.51

(0.93-2.46)

1.45

(0.39-5.36)

0.75

(0.12-4.43)

1.47

(0.83-2.60)

1.18

(0.98-1.41)

Q = 6.42

I 2 = 0 (0-60)

1%

(0-6)

PAPF

0

0

2%

0

2%

2%

0

2%

1%

0

6%

   

Heart problems

0.97

(0.66-1.43)

1.34

(0.88-2.04)

1.09

(0.60-1.99)

2.29

(0.44-11.7)

0.76

(0.45-1.27)

1.03

(0.41-2.57)

1.01

(0.28-3.59)

1.41

(1.04-1.91)

1.54

(0.56-4.18)

NC

NC

1.17

(0.98-1.39)

Q = 6.51

I 2 = 0 (0-65)

0

(0-9)

PAPF

0

2%

0

4%

0

0

0

9%

1%

     

Faint/blackout

1.13

(0.69-1.83)

0.90

(0.53-1.53)

1.09

(0.45-2.59)

0.12

(0.01-1.31)

1.46

(0.86-2.47)

1.95

(0.35-10.6)

0.89

(0.33-2.37)

1.04

(0.61-1.77)

0.51

(0.19-1.38)

0.46

(0.03-7.24)

1.78

(1.04-3.05)

1.11

(0.90-1.37)

Q = 12.01

I 2 = 17%

0

(0-11)

PAPF

0

0

0

0

3%

0

0

0

0

0

11%

 

(0-57)

 

COPD†

0.88

(0.51-1.50)

0.86

(0.55-1.33)

0.58

(0.32-1.06)

1.10

(0.35-3.47)

1.14

(0.75-1.73)

0.58

(0.27-1.27)

1.49

(0.76-2.90)

2.11

(1.42-3.2)

1.04

(0.46-2.37)

NC

0.86

(0.41-1.81)

1.08

(0.91-1.30)

Q = 20.63

I 2 = 56%

0

(0-4)

PAPF

0

0

0

0

1%

0

4%

4%

0

 

0

 

(12-78)

 

Skin disorders

0.84

(0.51-1.40)

2.57

(1.63-4.03)

1.11

(0.69-1.81)

0.26

(0.06-1.05)

0.99

(0.64-1.53)

0.47

(0.14-1.58)

1.10

(0.60-2.00)

0.38

(0.18-0.79)

NC

NC

0.84

(0.33-2.14)

1.05

(0.86-1.29)

Q = 28.73

I 2 = 72%

0

(0-4)

PAPF

0

4%

1%

0

0

0

0

0

  

0

 

(45-86)

 

Infarction/Angina‡

1.01

(0.77-1.33)

1.80

(1.13-2.88)

0.80

(0.43-1.50)

1.09

(0.26-4.40)

1.26

(0.72-2.21)

1.37

(0.53-3.54)

0.58

(0.07-4.31)

0.66

(0.43-1.1)

NC

0.87

(0.10-7.08)

0.46

(0.09-2.25)

1.02

(0.85-1.21)

Q = 12.41

I 2 = 28%

0

(0-3)

PAPF

0

3%

0

0

2%

1%

0

0

 

0

0

 

(0-65)

 

Persistent cough

0.85

(0.40-1.76)

0.89

(0.62-1.28)

1.04

(0.63-1.73)

2.30

(0.72-7.32)

0.89

(0.56-1.39)

0.94

(0.51-1.72)

0.52

(0.17-1.54)

0.77

(0.47-1.25)

NC

NC

1.06

(0.52-2.12)

0.94

(0.79-1.13)

Q = 5.24

I 2 = 0 (0-65)

0

(0-2)

PAPF

0

0

0

2%

0

0

0

0

  

0

   

Hypertension

0.79

(0.64-0.99)

0.74

(0.57-0.96)

1.01

(0.73-1.38)

1.79

(0.71-4.51)

0.97

(0.69-1.37)

0.86

(0.60-1.23)

1.47

(0.99-2.16)

1.03

(0.77-1.4)

1.48

(0.83-2.64)

1.31

(0.59-2.88)

0.66

(0.41-1.05)

0.92

(0.83-1.02)

Q = 18.51

I 2 = 46%

0

(0-23)

PAPF

0

0

0

21%

0

0

20%

2%

23%

15%

0

 

(0-73)

 

TOTAL PAPF

62.4%

48.4%

63.8%

63.8%

40.1%

45.0%

58.0%

54.0%

74.2%

61.2%

47.2%

   
  1. ¶Adjusted for age, sex, education and marital status; NC = not calculated because of small sample size; † Chronic obstructive pulmonary disease; ‡ Myocardial infarction; Rows in Italic show conditions not statistically associated with dependence which have positive PAPF values